Search Results | Clinical Cancer Research | American Association for Cancer Research

1-18 of 18

Sort by

Sort Order Select

Journal Articles

PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors

Clin Cancer Res (2019) 25 (14): 4375–4387.

DOI: https://doi.org/10.1158/1078-0432.CCR-18-4144

Published: 15 July 2019

View article

Includes: Supplementary data

Journal Articles

Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism

Clin Cancer Res (2019) 25 (7): 2305–2313.

DOI: https://doi.org/10.1158/1078-0432.CCR-18-2572

Published: 01 April 2019

View article

Includes: Supplementary data

Journal Articles

Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma

Eudocia Q. Lee, Dan G. Duda, Alona Muzikansky, Elizabeth R. Gerstner, John G. Kuhn, David A. Reardon, Lakshmi Nayak, Andrew D. Norden, Lisa Doherty, Debra LaFrankie, Jennifer Stefanik, Trupti Vardam, Katrina H. Smith, Christine McCluskey, Sarah Gaffey, Tracy T. Batchelor, Rakesh K. Jain, Patrick Y. Wen

Clin Cancer Res (2018) 24 (19): 4643–4649.

DOI: https://doi.org/10.1158/1078-0432.CCR-18-1025

Published: 01 October 2018

View article

Journal Articles

Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials

Clin Cancer Res (2017) 23 (19): 5745–5756.

DOI: https://doi.org/10.1158/1078-0432.CCR-16-2844

Published: 01 October 2017

View article

Journal Articles

Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma

Kensuke Tateishi, A. John Iafrate, Quan Ho, William T. Curry, Tracy T. Batchelor, Keith T. Flaherty, Maristela L. Onozato, Nina Lelic, Sudhandra Sundaram, Daniel P. Cahill, Andrew S. Chi, Hiroaki Wakimoto

Clin Cancer Res (2016) 22 (17): 4452–4465.

DOI: https://doi.org/10.1158/1078-0432.CCR-15-2274

Published: 31 August 2016

View article

Includes: Supplementary data

Journal Articles

Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma

William T. Curry, Jr, Ramana Gorrepati, Matthias Piesche, Tetsuro Sasada, Pankaj Agarwalla, Pamela S. Jones, Elizabeth R. Gerstner, Alexandra J. Golby, Tracy T. Batchelor, Patrick Y. Wen, Martin C. Mihm, Glenn Dranoff

Clin Cancer Res (2016) 22 (12): 2885–2896.

DOI: https://doi.org/10.1158/1078-0432.CCR-15-2163

Published: 14 June 2016

View article

Includes: Supplementary data

Journal Articles

Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate

Ovidiu C. Andronesi, Franziska Loebel, Wolfgang Bogner, Małgorzata Marjańska, Matthew G. Vander Heiden, A. John Iafrate, Jorg Dietrich, Tracy T. Batchelor, Elizabeth R. Gerstner, William G. Kaelin, Andrew S. Chi, Bruce R. Rosen, Daniel P. Cahill

Clin Cancer Res (2016) 22 (7): 1632–1641.

DOI: https://doi.org/10.1158/1078-0432.CCR-15-0656

Published: 31 March 2016

View article

Includes: Supplementary data

Journal Articles

A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients

Clin Cancer Res (2015) 21 (16): 3610–3618.

DOI: https://doi.org/10.1158/1078-0432.CCR-14-3220

Published: 13 August 2015

View article

Includes: Supplementary data

Journal Articles

Antiangiogenic Therapy for Glioblastoma: Current Status and Future Prospects

Tracy T. Batchelor, David A. Reardon, John F. de Groot, Wolfgang Wick, Michael Weller

Clin Cancer Res (2014) 20 (22): 5612–5619.

DOI: https://doi.org/10.1158/1078-0432.CCR-14-0834

Published: 13 November 2014

View article

Journal Articles

Targetable Signaling Pathway Mutations Are Associated with Malignant Phenotype in IDH-Mutant Gliomas

Hiroaki Wakimoto, Shota Tanaka, William T. Curry, Franziska Loebel, Dan Zhao, Kensuke Tateishi, Juxiang Chen, Lindsay K. Klofas, Nina Lelic, James C. Kim, Dora Dias-Santagata, Leif W. Ellisen, Darrell R. Borger, Sarah-Maria Fendt, Matthew G. Vander Heiden, Tracy T. Batchelor, A. John Iafrate, Daniel P. Cahill, Andrew S. Chi

Clin Cancer Res (2014) 20 (11): 2898–2909.

DOI: https://doi.org/10.1158/1078-0432.CCR-13-3052

Published: 29 May 2014

View article

Includes: Supplementary data

Journal Articles

Loss of the Mismatch Repair Protein MSH6 in Human Glioblastomas Is Associated with Tumor Progression during Temozolomide Treatment

Daniel P. Cahill, Kymberly K. Levine, Rebecca A. Betensky, Patrick J. Codd, Candice A. Romany, Linsey B. Reavie, Tracy T. Batchelor, P. Andrew Futreal, Michael R. Stratton, William T. Curry, A. John Iafrate, David N. Louis

Clin Cancer Res (2007) 13 (7): 2038–2045.

DOI: https://doi.org/10.1158/1078-0432.CCR-06-2149

Published: 02 April 2007

View article

Includes: Supplementary data

Journal Articles

The Effect of Enzyme-Inducing Antiseizure Drugs on the Pharmacokinetics and Tolerability of Procarbazine Hydrochloride

Stuart A. Grossman, Kathryn A. Carson, Tracy T. Batchelor, Glenn Lesser, Tom Mikkelsen, Jane B. Alavi, Surasak Phuphanich, Tarek Hammour, Joy D. Fisher, Jeffrey G. Supko

Clin Cancer Res (2006) 12 (17): 5174–5181.

DOI: https://doi.org/10.1158/1078-0432.CCR-06-0932

Published: 01 September 2006

View article

Journal Articles

Magnetic Resonance Imaging Characteristics Predict Epidermal Growth Factor Receptor Amplification Status in Glioblastoma

Manish Aghi, Paola Gaviani, John W. Henson, Tracy T. Batchelor, David N. Louis, Fred G. Barker, II

Clin Cancer Res (2005) 11 (24): 8600–8605.

DOI: https://doi.org/10.1158/1078-0432.CCR-05-0713

Published: 16 December 2005

View article

Journal Articles

YKL-40 Is a Differential Diagnostic Marker for Histologic Subtypes of High-Grade Gliomas

Catherine L. Nutt, Rebecca A. Betensky, Melissa A. Brower, Tracy T. Batchelor, David N. Louis, Anat O. Stemmer-Rachamimov

Clin Cancer Res (2005) 11 (6): 2258–2264.

DOI: https://doi.org/10.1158/1078-0432.CCR-04-1601

Published: 23 March 2005

View article

Journal Articles

Treatment of Relapsed Central Nervous System Lymphoma with High-Dose Methotrexate

Scott R. Plotkin, Rebecca A. Betensky, Fred H. Hochberg, Stuart A. Grossman, Glenn J. Lesser, L. Burt Nabors, Brian Chon, Tracy T. Batchelor

Clin Cancer Res (2004) 10 (17): 5643–5646.

DOI: https://doi.org/10.1158/1078-0432.CCR-04-0159

Published: 08 September 2004

View article

Journal Articles

Age-Dependent Prognostic Effects of Genetic Alterations in Glioblastoma

Tracy T. Batchelor, Rebecca A. Betensky, J. Matthew Esposito, Loc-Duyen D. Pham, Molly V. Dorfman, Nicole Piscatelli, Sarah Jhung, David Rhee, David N. Louis

Clin Cancer Res (2004) 10 (1): 228–233.

DOI: https://doi.org/10.1158/1078-0432.CCR-0841-3

Published: 20 January 2004

View article

Journal Articles

BCL-6 Expression Predicts Improved Survival in Patients with Primary Central Nervous System Lymphoma

Kristina M. Braaten, Rebecca A. Betensky, Laurence de Leval, Yoshifumi Okada, Fred H. Hochberg, David N. Louis, Nancy L. Harris, Tracy T. Batchelor

Clin Cancer Res (2003) 9 (3): 1063–1069.

Published: 01 March 2003

View article

Journal Articles

High-Dose Methotrexate for Intraocular Lymphoma

Tracy T. Batchelor, Gina Kolak, Roberto Ciordia, C. Stephen Foster, John W. Henson

Clin Cancer Res (2003) 9 (2): 711–715.

Published: 01 February 2003

View article

NARROW

PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors

Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism

Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma

Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials

Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma

Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma

Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate

A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients

Antiangiogenic Therapy for Glioblastoma: Current Status and Future Prospects

Targetable Signaling Pathway Mutations Are Associated with Malignant Phenotype in IDH-Mutant Gliomas

Loss of the Mismatch Repair Protein MSH6 in Human Glioblastomas Is Associated with Tumor Progression during Temozolomide Treatment

The Effect of Enzyme-Inducing Antiseizure Drugs on the Pharmacokinetics and Tolerability of Procarbazine Hydrochloride

Magnetic Resonance Imaging Characteristics Predict Epidermal Growth Factor Receptor Amplification Status in Glioblastoma

YKL-40 Is a Differential Diagnostic Marker for Histologic Subtypes of High-Grade Gliomas

Treatment of Relapsed Central Nervous System Lymphoma with High-Dose Methotrexate

Age-Dependent Prognostic Effects of Genetic Alterations in Glioblastoma

BCL-6 Expression Predicts Improved Survival in Patients with Primary Central Nervous System Lymphoma

High-Dose Methotrexate for Intraocular Lymphoma

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only